About ONCOC4 INC
OncoC4 is a biotechnology company focused on developing first-in-class and best-in-class medicines for hard-to-treat cancer and Alzheimer’s disease by leveraging immune checkpoints and innovative therapeutic modalities.
Development of first-in-class and best-in-class medicines for cancer and Alzheimer’s diseaseLeveraging immune checkpoints (CTLA-4, PD-1/VEGF, CD24, Siglec) to target cancer cells and boost immune responseEngineering diverse therapeutic modalities including monoclonal antibodies (mAbs), bispecific antibodies (BsAbs), and antibody-drug conjugates (ADCs)Global execution capabilities with headquarters in Maryland, United States
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ONCOC4 INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.